Reappraisal of Pretreatment Carcinoembryonic Antigen in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy

Tumori - Tập 99 Số 1 - Trang 93-99 - 2013
Seung‐Gu Yeo1,2, Dae Yong Kim1, Hee Jin Chang1, Ji Won Park1, Jae Hwan Oh1, Byung Chang Kim1, Ji Yeon Baek1, Sun Young Kim1, Tae Hyun Kim1,2
1Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang
2Department of Radiation Oncology, Soonchunhyang University College of Medicine, Cheonan, Korea

Tóm tắt

Aims and background

The pretreatment serum carcinoembryonic antigen (CEA) level is an independent prognostic factor in colorectal cancer. We aimed to investigate the significance of CEA as a prognostic or predictive factor in rectal cancer patients receiving preoperative chemoradiotherapy (CRT).

Methods and study design

In total, 609 patients with locally advanced (cStage II-III) mid to distal rectal cancer who underwent preoperative CRT and radical surgery between 2001 and 2008 were analyzed retrospectively. Predictive factors for pathologic CRT response were determined using multivariate logistic regression. A prognostic factor analysis was performed using the log-rank test and Cox proportional hazards regression.

Results

Elevated CEA levels (>5 ng/mL) were observed in 201 (33.0%) patients at diagnosis. Following preoperative CRT, downstaging (ypStage 0-I) occurred in 255 (41.9%) patients, of whom 88 had pathologic complete tumor regression. Pretreatment CEA was significantly associated with pathologic CRT response in terms of downstaging and tumor regression grade, and was the most relevant predictive factor. After a median follow-up period of 60 months, the 5-year disease-free and overall survival rates were 76.2% and 84.6%, respectively. Prognostic factors independently associated with recurrence or survival included ypStage, circumferential resection margin, and histologic grade.

Conclusions

In patients with rectal cancer who received preoperative CRT, the pretreatment CEA level was a significant and independent predictor of pathologic CRT response. However, it may not be able to predict long-term outcomes independently of ypStage.

Từ khóa


Tài liệu tham khảo

Compton C., 2000, Cancer, 88, 1739, 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T

American Joint Committee on Cancer., 2010, AJCC Cancer Staging Manual, 7, 143, 10.1007/978-0-387-88441-7_14

Wanebo H.J., 1978, N Engl J Med, 299, 448, 10.1056/NEJM197808312990904

Carriquiry L.A., 1999, Dis Colon Rectum, 42, 921, 10.1007/BF02237104

Park Y.J., 1999, Int J Colorectal Dis, 14, 101, 10.1007/s003840050193

Lindmark G., 1995, Br J Cancer, 71, 1090, 10.1038/bjc.1995.211

Peng J.J., 2007, World J Gastroenterol, 13, 3009, 10.3748/wjg.v13.i21.3009

Sauer R., 2004, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694

Kim T.H., 2010, Int J Radiat Oncol Biol Phys, 77, 1158, 10.1016/j.ijrobp.2009.06.019

Yeo S.G., 2010, Ann Surg, 252, 998, 10.1097/SLA.0b013e3181f3f1b1

Guillem J.G., 2005, Ann Surg, 241, 829, 10.1097/01.sla.0000161980.46459.96

Coco C., 2006, Dis Colon Rectum, 49, 311, 10.1007/s10350-005-0291-6

Quah H.M., 2008, Cancer, 113, 57, 10.1002/cncr.23516

Shivnani A.T., 2007, Am J Surg, 193, 389, 10.1016/j.amjsurg.2006.09.030

Onaitis M.W., 2001, Ann Surg, 233, 778, 10.1097/00000658-200106000-00007

American Joint Committee on Cancer., 2002, AJCC Cancer Staging Manual, 6, 113, 10.1007/978-1-4757-3656-4_12

Dworak O., 1997, Int J Colorectal Dis, 12, 19, 10.1007/s003840050072

Locker G.Y., 2006, J Clin Oncol, 24, 5313, 10.1200/JCO.2006.08.2644

10.1093/clinchem/47.4.624

Myerson R.J., 2001, Int J Radiat Oncol Biol Phys, 50, 665, 10.1016/S0360-3016(01)01476-6

Chan A.K., 2005, Int J Radiat Oncol Biol Phys, 61, 665, 10.1016/j.ijrobp.2004.06.206

Ishihara S., 2010, Int J Colorectal Dis, 25, 1417, 10.1007/s00384-010-1051-1

Nagtegaal I.D., 2008, J Clin Oncol, 26, 303, 10.1200/JCO.2007.12.7027

Perez R.O., 2009, Dis Colon Rectum, 52, 1137, 10.1007/DCR.0b013e31819ef76b

Jang N.Y., 2011, Dis Colon Rectum, 54, 245, 10.1007/DCR.0b013e3181fcee68

Park J.W., 2009, Int J Radiat Oncol Biol Phys, 74, 810, 10.1016/j.ijrobp.2008.08.057

Das P., 2007, Cancer, 109, 1750, 10.1002/cncr.22625

Yoon S.M., 2007, Int J Radiat Oncol Biol Phys, 69, 1167, 10.1016/j.ijrobp.2007.04.047

Park Y.A., 2006, J Surg Oncol, 93, 145, 10.1002/jso.20320

Yeo S.G., 2010, Jpn J Clin Oncol, 40, 754, 10.1093/jjco/hyq062

Yeo S.G., 2012, Dis Colon Rectum, 55, 686, 10.1097/DCR.0b013e3182505080

Weissenberger C., 2005, Anticancer Res, 25, 1787

Riesterer O., 2007, J Clin Oncol, 25, 4075, 10.1200/JCO.2007.11.8497

Thông tin
Thông tin xuất bản

Tumori

Tập 99 Số 1

93-99

Thông tin tác giả